Advertisement
For patients with chronic lumbar back pain

Basivertebral Nerve Ablation Beneficial for Chronic Back Pain

0
Improvement in self-reported outcomes at three months in patients with chronic lumbar back pain
The most important concepts of obesity prevention and treatment are not adequately represented on the U.S. Medical Licensing Examination Step examinations

Obesity Underrepresented in Medical Licensing Exams

0
Exam items primarily address diagnosis and treatment of obesity-related comorbid conditions
Just 20 minutes of moderate exercise may reduce inflammation in the body

Brief Bouts of Exercise Can Reduce Inflammation

0
20 minutes on a treadmill linked to drop in immune cells tied to inflammation
Over a decade

Number of Infants Born to Women Using Opioids Up Sharply

0
Few treatment programs deal with substance abuse in expectant moms, federal report says
Patient- and provider-based interventions do not improve osteoarthritis outcomes

Interventions Don’t Improve Osteoarthritis Outcomes

0
No benefit for patient- and provider-based interventions compared with usual care
Many doctors bill their private-paying patients two

Physician Excess Charges Create Financial Burden for Patients

0
Fees affect uninsured Americans, privately insured patients who use out-of-network physicians
For patients with chronic pain receiving opioids

Patient Perception of Provider Concern Impacts Satisfaction

0
Findings in private practice pain management clinic for patients prescribed opioids
Transcutaneous electrical nerve stimulation can reduce pain during office hysterectomy without sedation

TENS Relieves Pain During Office Hysterectomy Without Sedation

0
Reduction in pain, and significant increase in patient satisfaction for active TENS group
Current medical science has proven there are legitimate medical uses for marijuana and cannabis-derived drugs

New Comprehensive Report Looks at Benefits, Harms of Cannabis

0
Can ease chronic pain, chemo-related nausea, muscle spasms in MS, but researchers cite risks, too
The excessive regulatory regime at the U.S. Food and Drug Administration is an important driver of high drug prices

Excessive FDA Regulation Driving High Drug Prices

0
First-in-class drugs are fast-tracked while follow-on drugs can take up to 15 years to be approved